SCHEMBL5654011

SCHEMBL5654011

O=C1OC(COC(=O)c2cc(Br)c(Br)s2)C=C1c1cccc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GSK3B P49841 2/20 0.34
POLB P06746 2/20 0.34
PKM P14618 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRM3 P20309 3/20 0.32
TP53 P04637 2/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652657 0.90 CSNK2A2 (0.37) CSNK2A2CSNK2BCSNK2A1MAPTMEN1
SCHEMBL5655483 0.88 CSNK2A2 (0.36) CSNK2A2CSNK2BCSNK2A1MAPTMEN1
SCHEMBL5655324 0.82 RAB9A (0.41) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL5654798 0.82 MEN1 (0.36) CSNK2A2CSNK2BCSNK2A1MAPTMEN1
SCHEMBL5652924 0.80 MEN1 (0.42) MAPTMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL5653044 0.78 L3MBTL1 (0.36) MEN1KMT2APOLBTRPM8L3MBTL1
SCHEMBL5653895 0.76 CYP1A1 (0.42) MAPTMEN1KMT2AL3MBTL1LMNA
SCHEMBL5654947 0.76 L3MBTL1 (0.40) MAPTMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL5657263 0.76 BRD4 (0.34) MAPTMEN1KMT2ATRPM8ALDH1A1
SCHEMBL5653034 0.76 GSTO1 (0.34) MAPTTRPM8ALDH1A1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259948-A1 Compounds with antifungal properties and process thereof ADH5, GK, AKR1C3 CSNK2A2 2506/4885CSNK2B 2393/4885CSNK2A1 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.